Flores, Zosima M.

HRN: 13-32-32  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2024
10/20/2024
IVT
4.5g
Q6h
CAP-HR
Waiting Final Action 
10/13/2024
LEVOFLOXACIN 500MG (TAB)
10/13/2024
10/20/2024
PO
500mg
OD
CAP-HR
Waiting Final Action 
10/17/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2024
10/24/2024
IV
300mg
Q6
Soft Tissue Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: